2011-11-15T10:28:48-06:00 2010-12-31 E COHEN AND COMPANY CPAS ONE RESEARCH COURT SUITE 101 ROCKVILLE MD 20850 990 2010-01-01 521376386 INTERNATIONAL CANCER ALLIANCE FOR RESEARCH AND EDUCATION INTE 3016563461 4601B LYNN BURKE ROAD MONROVIA MD 21770 DR W DAVID HANKINS PHD 3016563461 2011-11-14 1 ERIC COHEN CPA 3019176200 2010 2016-02-24 21:20:13Z DR W DAVID HANKINS PH 4601B LYNN BURKE ROAD MONROVIA MD 21770 441567 0 X WWW.ICARE.ORG X 1984 MD THE ORGANIZATIONS MISSION IS TO IDENTIFY NEW DRUG TOOLS FOR THE DOCTORS OF CURRENT CANCER PATIENTS BY: CONVENING ELITE GLOBAL INVESTIGATIONAL TEAMS (I-TEAMS) COMPOSED OF DOCTORS, PATIENTS AND SCIENTISTS; ACCELERATING CLINICAL TRIALS OF THESE POTENTIAL NEW THERAPIES; AND ACTIVELY PROMOTE CREATIVITY AND INNOVATIVE THINKING IN PATIENT-RELATED TREATMENT AND RESEARCH. 4 4 0 50 0 0 33910 440964 0 0 0 603 0 0 33910 441567 0 235000 0 0 0 80203 0 0 0 9624 39353 9624 354556 24286 87011 310 158097 70721 141497 -70411 16600 X THE ORGANIZATIONS MISSION IS TO IDENTIFY NEW DRUG TOOLS FOR THE DOCTORS OF CURRENT CANCER PATIENTS BY: CONVENING ELITE GLOBAL INVESTIGATIONAL TEAMS (I-TEAMS) COMPOSED OF DOCTORS, PATIENTS AND SCIENTISTS; ACCELERATING CLINICAL TRIALS OF THESE POTENTIAL NEW THERAPIES; AND ACTIVELY PROMOTE CREATIVITY AND INNOVATIVE THINKING IN PATIENT-RELATED TREATMENT AND RESEARCH. 0 0 322627 235000 I-TEAM PROGRAM:AIMS TO STIMULATE CREATIVE THINKING ABOUT NEW AND EXISTING TREATMENTS. FURTHERMORE, TO ACCELERATE INNOVATIVE THERAPEUTIC APPROACHES INTO HUMAN AND CLINICAL TRIALS THAT BENEFIT THE PATIENT. 322627 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 1 0 MD X X THE ORGANIZATION 3016563461 4601B LYNN BURKE ROAD MONROVIA MD 21770 DR W DAVID HANKINS PHD 5.00 X X 0 0 8603 DR DONNA M WILLIAMS 5.00 X X 8182 0 0 DR CHARLES ROGERS PHD 2.00 X 2000 0 0 DR WILLIAM HEARL PHD 2.00 X 0 0 0 DR GEORGE HEMSTREET MD PHD 2.00 X 0 0 0 10182 0 8603 0 0 0 0 0 440964 440964 603 603 441567 0 0 603 235000 235000 80203 57302 22901 2550 1862 688 10000 8000 2000 1200 872 328 13295 9340 3955 855 621 234 SUPPLIES 6617 6028 589 TELEPHONE 2952 2145 807 BOOKS & SUBSCRIPTIONS 1084 876 208 MEMBERSHIP DUES 454 330 124 POSTAGE 346 251 95 354556 322627 31929 0 310 157356 741 310 158097 2967 70778 15000 17965 52754 52754 70721 141497 X -70411 -5598 22198 -70411 16600 310 158097 87011 0 X 1 0 0 X 0 X 38969 24460 12643 33910 440964 550946 38969 24460 12643 33910 440964 550946 137938 413008 603 603 551549 0.74880 0.84130 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 PAYROLL TAXES PAYABLE 52754 52754 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: NO PROVISION HAS BEEN MADE FOR INCOME TAXES, SINCE THE ORGANIZATION HAS BEEN DETERMINED TO BE EXEMPT FROM INCOME TAX PURSUANT TO INTERNAL REVENUE CODE SECTION 501(C)(3) AND THERE WAS NO NET UNRELATED BUSINESS TAXABLE INCOME DURING THE YEAR. THE ORGANIZATION ADOPTED THE FINANCIAL ACCOUNTING STANDARDS BOARD FASB ASC 740-10, INCOME TAXES, WHICH REQUIRES AN ASSESSMENT OF UNCERTAINTY IN INCOME TAXES AND CERTAIN FINANCIAL STATEMENT DISCLOSURES RELATING TO UNRECOGNIZED TAX BENEFITS. FOR THE YEAR ENDED DECEMBER 31, 2010 THE ORGANIZATION HAS DOCUMENTED ITS CONSIDERATION OF FASC ASC 740-10 AND DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. 1 HARVARD UNIVERSITY AUBURN STREET CAMBRIDGE MA 02138 042103580 25000 TO SUPPORT RESEARCH IN CANCER STEM CELL THERAPEUTICS. UNIVERSITY OF MASSACHUSETTS 364 PLANTATION STREET WORCESTER MA 01605 043108190 25000 TO SUPPORT RNAI RESEARCH IN CANCER. UNIVERSITY OF VIRGINIA 400 RAY C HUNT DRIVE BOX 400807 CHARLOTTEVILLE VA 22904 546001796 10000 FOR LIPIDS AND CANCER RESEARCH. UNIVERSITY NORTH CAROLINA 208 W FRANKLIN STREET CAHPEL HILL NC 27514 566001393 50000 TO SUPPORT RESEARCH ON NORMAL AND CANCER STEM CELLS IN THE LIVER. UNIVERSITY OF BRITISH COLUMBIA 2329 WEST MALL VANCOUVER BC CA 521559117 50000 TO SUPPORT WORK IN THE TRANSPLANTATION OF HUMAN CELLS IN MICE. JOHN HOPKINS UNIVERSITY 3400 N CHARLES STREET BALTIMORE MD 21218 520595110 75000 TO SUPPORT LIVER MOLECULAR AND CELL BIOLOGY RESEARCH. 6 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: ICARE MONITORS THE USE OF GRANT FUNDS IN THE U.S. BY REQUIRING THAT ALL GRANTEES PROVIDE A FULL ACCOUNTING OF GRANT EXPENDITURES AND ACCOMPLISHMENTS TO ICARE. FURTHER, ALL GRANTEES AGREE TO INCLUDE RECOGNITION ON PUBLICATIONS AND PATENTS TO ICARE. DR W DAVID HANKINS PHD GENERAL OPERATIONS X 17965 17965 0 1 0 17965 FORM 990, PART VI, SECTION B, LINE 11 A COPY OF THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS VIA EMAIL FOR REVIEW AND APPROVAL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS MONITORED AND ENFORCED AT ANNUAL BOARD MEETINGS. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTORAND KEY EMPLOYEE SALARIES AND BENEFITS ARE REVIEWED AND APPROVED BY THE BOARD ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.